| NCT07542730 | University of Rochester | Pain|Abortion|Anxiety | 2026-05 | PHASE4 |
| NCT00490009 | Susan Knox|Corixa Corporation|GlaxoSmithKline | Lymphoma | 2004-09 | PHASE2 |
| NCT03435692 | Seattle Children´s Hospital | Hip Surgery|Post Operative Pain Control | 2011-07-15 | NA |
| NCT02098499 | United States Naval Medical Center, Portsmouth | Migraine Headaches|Nausea|Restlessness | 2013-06-12 | PHASE4 |
| NCT03330028 | M.D. Anderson Cancer Center | Diseases of Oesophagus Stomach and Duodenum | 2017-10-27 | PHASE1 |
| NCT01289938 | Matthias Schwab | Drug Metabolism, Poor, CYP2D6-RELATED | 2009-07 | PHASE1 |
| NCT04846348 | Joseph Butterfield | Cutaneous Mastocytoses | 2021-07-26 | PHASE2 |
| NCT05302388 | Shanghai Institute Of Biological Products|The First Affiliated Hospital of Bengbu Medical University | Asymptomatic Hyperuricemia | 2022-04-11 | PHASE1 |
| NCT00682734 | Montefiore Medical Center | Migraine | 2008-04 | PHASE3 |
| NCT06704620 | Tianjin Medical University Cancer Institute and Hospital | Advanced and Metastatic NSCLC | 2024-12 | PHASE3 |
| NCT00515073 | M.D. Anderson Cancer Center | Endometrial Cancer | 2001-04 | PHASE2 |
| NCT00887640 | Duke University|National Comprehensive Cancer Network | Prostate Cancer | 2009-07 | PHASE2 |
| NCT04189588 | TerSera Therapeutics LLC | Oncology Patients Receiving Chemotherapy | 2020-03-25 | PHASE2 |
| NCT06702670 | The University of Texas Health Science Center, Houston | Labor Dystocia | 2025-03-25 | PHASE2|PHASE3 |
| NCT00076752 | National Cancer Institute (NCI) | Lupus Erythematosus, Systemic | 2004-01-30 | PHASE2 |
| NCT02188719 | National Institute of Allergy and Infectious Diseases (NIAID)|Rho Federal Systems Division, Inc. | Liver Transplantation | 2014-12-17 | PHASE1 |
| NCT02339155 | Emergent BioSolutions|GlaxoSmithKline | Infections, Bacterial | 2015-02-24 | PHASE4 |
| NCT03554473 | National Cancer Institute (NCI) | Carcinoma, Small Cell|Lung Cancer|Small Cell Lung Cancer | 2018-09-11 | PHASE1|PHASE2 |
| NCT02463929 | Universitas Diponegoro|Permata Sari Hospital for Plastic Surgery | Specified Sedative|Hypnotic | 2014-04 | PHASE4 |
| NCT01017731 | Eli Lilly and Company | Cancer|Solid Tumor | 2009-11 | PHASE2 |
| NCT01858090 | Baskent University | Elective Caesarean Section Surgeries | 2009-01 | PHASE3 |
| NCT00937924 | University of California, Irvine | Endoscopic Ultrasound (EUS)|Endoscopic Retrograde Cholangiopancreatography (ERCP) | 2008-02 | PHASE4 |
| NCT05405166 | Sanofi | Plasma Cell Myeloma Recurrent | 2022-06-23 | PHASE3 |
| NCT05219604 | Dent Neuroscience Research Center | Central Nervous System Effects of Diphenhydramine|Pharmacokinetics of Diphenhydramine | 2022-03-15 | PHASE4 |
| NCT02295280 | St. Louis University | Headache | 2012-01 | NA |
| NCT00588159 | Michelle Kinney | Pain | 2007-06 | NA |
| NCT01967433 | University of Oklahoma | Colonoscopy|Adjunct Anesthesia Medication | 2013-12 | PHASE4 |
| NCT00762749 | Johnson & Johnson Consumer and Personal Products Worldwide | Allergic Rhinitis | 2008-09 | PHASE1 |
| NCT04308837 | Icahn School of Medicine at Mount Sinai | Gastric Cancer|Stomach Cancer | 2018-12-03 | PHASE2 |
| NCT02657031 | University Medical Center of Southern Nevada | Headache | 2016-03-17 | PHASE4 |
| NCT01053208 | Dr. Reddy´s Laboratories Limited | Healthy | 2008-04 | PHASE1 |
| NCT01825941 | Montefiore Medical Center | Migraine | 2013-04 | PHASE4 |
| NCT02452528 | Arrowhead Pharmaceuticals | Chronic Hepatitis B | 2015-08 | PHASE2 |
| NCT02972502 | OhioHealth | Headache, Migraine | 2014-02 | PHASE4 |
| NCT00186628 | Stanford University|The Leukemia and Lymphoma Society|National Cancer Institute (NCI) | Leukemia, Mast-Cell|Mantle-cell Lymphoma | 2005-06 | PHASE2 |
| NCT03185130 | University Medical Center of Southern Nevada | Headache | 2017-05-16 | PHASE4 |
| NCT04270409 | Sanofi | Plasma Cell Myeloma | 2020-06-16 | PHASE3 |
| NCT01837446 | Isfahan University of Medical Sciences | Stomatitis | 2011-07 | PHASE2|PHASE3 |
| NCT04432597 | National Cancer Institute (NCI) | HPV Positive Cancer|Vulvar, Vaginal, Penile, Rectal Cancer|Anal Cancer|Oropharyngeal Cancer|Cervical Cancer | 2020-08-11 | PHASE1|PHASE2 |
| NCT04580121 | Hoffmann-La Roche | Acute Myeloid Leukemia | 2020-11-04 | PHASE1 |
| NCT04918147 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Bristol-Myers Squibb|Rho Federal Systems Division, Inc. | IgG4 Related Disease|IgG4-RD | 2021-10-13 | PHASE2 |
| NCT00137202 | United States Army Institute of Surgical Research | Itching | 2005-06 | NA |
| NCT01737931 | Otsuka Pharmaceutical Co., Ltd. | Healthy | 2012-08 | PHASE1 |
| NCT02474199 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation in Children|Rho Federal Systems Division, Inc. | Liver Transplant Recipient|Living Donor (of the Respective Liver Transplant Recipient) | 2016-06-06 | PHASE1|PHASE2 |
| NCT02363946 | Arrowhead Pharmaceuticals | Alpha-1 Antitrypsin Deficiency | 2015-02 | PHASE1 |
| NCT01321021 | Prof. Dominique de Quervain, MD|Clinical Trial Unit, University Hospital Basel, Switzerland | Memory, Long-Term|Memory, Short-Term | 2011-03 | NA |
| NCT00226941 | George Albert Fisher|Bristol-Myers Squibb | Rectal Cancer|Colo-rectal Cancer | 2004-06 | PHASE1|PHASE2 |
| NCT03805932 | National Cancer Institute (NCI) | Hairy Cell Leukemia | 2019-10-03 | PHASE1 |
| NCT01985789 | Don Cockcroft | Asthma | 2013-11 | PHASE4 |
| NCT05704049 | Sanofi | Relapsed+Refractory Multiple Myeloma | 2023-04-05 | PHASE2 |
| NCT02441894 | Sanofi | Prostate Cancer | 2015-04 | PHASE4 |
| NCT04660799 | Hoffmann-La Roche | Lymphoma, Large B-Cell, Diffuse | 2021-02-24 | PHASE2 |
| NCT00030992 | National Cancer Institute (NCI) | Renal Cell Carcinoma | 2002-02 | PHASE2 |
| NCT02535416 | Arrowhead Pharmaceuticals | Healthy | 2015-09 | PHASE1 |
| NCT00475306 | Montefiore Medical Center | Nausea|Extrapyramidal Symptoms | 2007-05 | PHASE4 |
| NCT00923910 | National Cancer Institute (NCI) | Leukemia, Acute Myelogenous (AML)|Leukemia, Acute Lymphocytic (ALL)|Leukemia, Chronic Myelogenous (CML)|Myelodysplastic Syndrome (MDS)|Non-Hodgkin´s Lymphoma (NHL) | 2008-02-22 | PHASE1|PHASE2 |
| NCT07358689 | Tianjin Medical University Cancer Institute and Hospital | NSCLC | 2026-01-30 | PHASE2 |
| NCT00991809 | Johns Hopkins University|National Institute on Drug Abuse (NIDA) | Hyperalgesia | 2009-02 | NA |
| NCT07570173 | Merck Sharp & Dohme LLC | B-cell Acute Lymphoblastic Leukemia | 2026-05-08 | PHASE2|PHASE3 |
| NCT01086540 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Rho Federal Systems Division, Inc. | Systemic Sclerosis-Associated PAH | 2011-06-24 | PHASE2 |
| NCT05298683 | Hellenic Society of Hematology|Sanofi | Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases | 2022-05 | PHASE2 |
| NCT03424135 | Bayer | Clinical Pharmacology | 2018-03-02 | PHASE1 |
| NCT07285031 | University of British Columbia | Histamine|Exercise | 2025-12 | NA |
| NCT04224558 | Cedars-Sinai Medical Center | Crohn Disease | 2019-11-15 | PHASE1|PHASE2 |
| NCT01177852 | Ache Laboratorios Farmaceuticos S.A. | Inflammation|Cough|Rhinitis | 2011-10 | PHASE3 |
| NCT03396250 | Bayer | Pain | 2018-02-12 | PHASE1 |
| NCT03030417 | National Cancer Institute (NCI) | Solid Tumors|Lymphoma | 2017-02-27 | PHASE1 |
| NCT02476058 | Janssen-Cilag International NV | Major Depressive Disorder | 2015-06-11 | PHASE1 |
| NCT02655354 | University of Washington|National Institutes of Health (NIH)|National Institute of Mental Health (NIMH)|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Posttraumatic Stress Disorder|Depression|Alcohol-Related Disorders|Suicidal Ideation|Substance-Related Disorders|Mild Cognitive Impairment|Quality of Life|Pain|Wounds and Injury|Brain Injuries|Chronic Disease | 2015-10 | NA |
| NCT01769586 | VA Connecticut Healthcare System | Sedation|Endoscopy | 2013-02 | NA |
| NCT06182098 | Dayton Children´s Hospital | Migraine|Migraine in Children | 2023-06-27 | NA |
| NCT04862585 | Ohio State University Comprehensive Cancer Center | Anatomic Stage 0 Breast Cancer AJCC v8|Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Breast Carcinoma|Prognostic Stage 0 Breast Cancer AJCC v8|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8 | 2021-10-07 | PHASE2|PHASE3 |
| NCT01669967 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph´s | Neuropathic Pain | 2011-09 | NA |
| NCT02711826 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Kidney Transplant|Adult Living Donor Kidney Transplant Recipients|Renal Transplant|Living Kidney Donor | 2016-09-20 | PHASE1|PHASE2 |
| NCT05627557 | Hoffmann-La Roche | Childhood Idiopathic Nephrotic Syndrome | 2023-03-29 | PHASE3 |
| NCT00837941 | Merck Sharp & Dohme LLC | Painful Diabetic Neuropathy | 2009-04 | PHASE2 |
| NCT06019728 | Sanofi | Fabry´s Disease | 2023-11-10 | PHASE4 |
| NCT04093271 | LifeSeasons Inc.|KGK Science Inc. | Sleep|Healthy | 2019-09-24 | PHASE1 |
| NCT05039619 | Hoffmann-La Roche|Genentech, Inc. | Lupus Nephritis | 2022-05-12 | PHASE2 |
| NCT02389829 | Montefiore Medical Center | Migraine | 2015-03 | PHASE4 |
| NCT01264939 | Genentech, Inc. | Chronic Idiopathic Urticaria | 2011-02 | PHASE3 |
| NCT05232825 | Hoffmann-La Roche | Relapsing Multiple Sclerosis|Primary Progressive Multiple Sclerosis | 2022-05-03 | PHASE3 |
| NCT04294459 | Sanofi | Immune System Disorder | 2020-06-18 | PHASE1|PHASE2 |
| NCT01059786 | National Cancer Institute (NCI) | Hairy Cell Leukemia | 2010-07-01 | PHASE2 |
| NCT00641797 | Lehigh Valley Hospital | Benign Paroxysmal Positional Vertigo | 2006-11 | NA |
| NCT01119222 | Pfizer | Healthy | 2008-07 | PHASE1 |
| NCT02648490 | Henlix, Inc | Solid Tumour | 2016-09 | PHASE1 |
| NCT01067677 | Franklyn Cladis | Post Operative Nausea and Vomiting|Rescue Emetic Therapy | 2010-02 | NA |
| NCT05036174 | Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology | Osteoarthritis | 2021-09 | NA |
| NCT01204255 | Virginia Commonwealth University|National Cancer Institute (NCI)|American Cancer Society, Inc. | Healthy | 2010-11-15 | NA |
| NCT04237090 | Ciusss de L´Est de l´?le de Montréal | Breast Cancer|Lung Cancer|Ovarian Cancer|Oesophageal Cancer|Head Cancer Neck|Cervical Cancer|Endometrial Cancer | 2020-02-14 | PHASE3 |
| NCT01666678 | Bayer | Therapeutic Equivalence | 2012-01 | PHASE1 |
| NCT03220958 | Montefiore Medical Center | Post-Traumatic Headache | 2017-08-01 | PHASE3 |
| NCT03107182 | University of Chicago | HPV-Related Squamous Cell Carcinoma|HNSCC | 2017-06-27 | PHASE2 |
| NCT03142165 | Bristol-Myers Squibb | Fibrosis | 2017-05-11 | PHASE1 |
| NCT00078559 | University of Wisconsin, Madison|Immune Tolerance Network (ITN) | Kidney Transplantation|Kidney Disease | 2003-11 | PHASE1|PHASE2 |
| NCT05501678 | Stanford University|National Institutes of Health (NIH) | Autism|Autism Spectrum Disorder | 2023-08-09 | PHASE2 |
| NCT00000875 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | | NA |
| NCT03324113 | Sanofi | Neoplasm Malignant | 2017-10-17 | PHASE1 |
| NCT06819774 | Shandong New Time Pharmaceutical Co., LTD | Acute Urticaria | 2024-04-22 | PHASE3 |
| NCT01455389 | Genprex, Inc. | Lung Cancer | 2014-02 | PHASE1|PHASE2 |
| NCT04268498 | University of Miami|Amgen|Janssen Pharmaceuticals | Multiple Myeloma | 2020-02-11 | PHASE2 |
| NCT02858310 | National Cancer Institute (NCI) | Papillomavirus Infections|Cervical Intraepithelial Neoplasia|Carcinoma In Situ|Vulvar Neoplasms|Vulvar Diseases | 2017-01-27 | PHASE1|PHASE2 |
| NCT07472413 | University of Miami | Multiple Sclerosis | 2026-07-01 | PHASE3 |
| NCT02356159 | National Cancer Institute (NCI) | Myelodysplastic Syndromes|Hodgkin´s Lymphoma|Non-Hodgkin´s Lymphoma|Acute Leukemia|Multiple Myeloma | 2015-09-24 | PHASE1|PHASE2 |
| NCT01712828 | Celgene|Covance | Healthy | 2012-10-01 | PHASE1 |
| NCT05676216 | National Taiwan University Hospital | Peripheral Vertigo | 2023-01-07 | NA |
| NCT02061293 | NYU Langone Health|Heffter Research Institute|University of New Mexico | Alcohol Dependence | 2014-06 | PHASE2 |
| NCT04599634 | National Cancer Institute (NCI) | Follicular Lymphoma|Marginal Zone Lymphoma|Mantle Cell Lymphoma|Chronic Lymphocytic Lymphoma|B-Cell Lymphoma | 2021-12-16 | PHASE1 |
| NCT02374567 | Hannover Medical School | Dementia|Depression|Schizophrenia|Psychosomatic Disorders|Anxiety Disorders | 2015-01 | PHASE3 |
| NCT06070649 | Yale University|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder (AUD)|Alcohol-Related Disorders|Alcohol Use | 2025-08-04 | PHASE1 |
| NCT04840615 | National Cancer Institute (NCI) | Mesothelioma | 2021-06-11 | PHASE1 |
| NCT05285813 | M.D. Anderson Cancer Center | AML|MDS | 2022-05-06 | PHASE2 |
| NCT00223691 | Vanderbilt University | Autonomic Failure|Orthostatic Hypotension | 2002-03 | PHASE1 |
| NCT02037126 | University of Alabama at Birmingham | Cocaine-Related Disorders | 2015-05 | PHASE2 |
| NCT04963296 | Hoffmann-La Roche | Systemic Lupus Erythematosus | 2021-10-26 | PHASE3 |
| NCT00282347 | Genentech, Inc. | Lupus Nephritis | 2006-01 | PHASE3 |
| NCT02029638 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Kidney Transplantation | 2014-01-07 | PHASE2 |
| NCT01053338 | Dr. Reddy´s Laboratories Limited | Healthy | 2008-04 | PHASE1 |
| NCT06310642 | CHRISTUS Health | AMS|Acute Mountain Sickness | 2021-05-20 | PHASE4 |
| NCT01411124 | XenoPort, Inc. | Restless Legs Syndrome (RLS) | 2011-06 | PHASE1 |
| NCT05896228 | Benjamin T Diamond, MD|Bristol-Myers Squibb | Refractory Multiple Myeloma|Relapsed Multiple Myeloma | 2024-02-20 | PHASE2 |
| NCT01965301 | Bioprojet | Healthy Male Volunteers | 2014-10 | PHASE1 |
| NCT01985126 | Janssen Research & Development, LLC | Multiple Myeloma | 2013-09-27 | PHASE2 |
| NCT01451762 | Northwestern University | Surgery|Pain | 2011-09 | NA |
| NCT05244460 | Mercy Health Ohio|Lake Erie College of Osteopathic Medicine | Cannabis Hyperemesis Syndrome | 2021-12-02 | PHASE3 |
| NCT00961792 | University of Chicago|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcoholism | 2004-03 | NA |
| NCT04862221 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Ann & Robert H Lurie Children´s Hospital of Chicago | Acute Liver Failure|Fulminant Hepatic Failure|Hepatic Encephalopathy|Acute Liver Injury|Immune Dysregulation | 2022-02-09 | PHASE2 |